DrugPatentWatch Database Preview

Tirbanibulin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tirbanibulin and what is the scope of freedom to operate?

Tirbanibulin is the generic ingredient in one branded drug marketed by Almirall and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Tirbanibulin has ninety-five patent family members in twenty-two countries.

One supplier is listed for this compound.

Summary for tirbanibulin

International Patents:	95
US Patents:	7
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	48
Patent Applications:	390
What excipients (inactive ingredients) are in tirbanibulin?	tirbanibulin excipients list
DailyMed Link:	tirbanibulin at DailyMed

US Patents and Regulatory Information for tirbanibulin

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Almirall	KLISYRI	tirbanibulin	OINTMENT;TOPICAL	213189-001	Dec 14, 2020		RX	Yes	Yes
Almirall	KLISYRI	tirbanibulin	OINTMENT;TOPICAL	213189-001	Dec 14, 2020		RX	Yes	Yes			Y
Almirall	KLISYRI	tirbanibulin	OINTMENT;TOPICAL	213189-001	Dec 14, 2020		RX	Yes	Yes			Y	Y
Almirall	KLISYRI	tirbanibulin	OINTMENT;TOPICAL	213189-001	Dec 14, 2020		RX	Yes	Yes			Y	Y

International Patents for tirbanibulin

Country	Patent Number	Estimated Expiration
Japan	2017193587
Taiwan	200800952
European Patent Office	2155681
Austria	544748